Hear how ProspectDTX will Manage Chemotherapy side effects-Avoid E.R. Readmittance

ProsperDTX helps improve the lives of cancer patients using proprietary, causal machine learning technology to provide a personal advocate 24/7 with targeted support to cancer patients so that they may live better lives. ProsperDTX is bridging the gaps in the continuity of cancer care through a unique digital health platform, engaging patients and providing personalized care recommendations. Cary is joined by ProsperDTX co-founders Joseph Swiader, CEO, and Robert Goldberg, PhD, CSO.

Episode metadata supplied by the publisher feed · Published Aug 23, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Hear how ProspectDTX will Manage Chemotherapy side effects-Avoid E.R. Readmittance

0:00 36:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of America's Healthcare Advocate?

This episode is 36 minutes long.

When was this America's Healthcare Advocate episode published?

This episode was published on August 23, 2022.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this America's Healthcare Advocate episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!